Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up

These are exciting times in the development of new immunotherapeutic strategies for cancer therapy. In particular, synthetic peptide-based vaccines, aiming at the induction of T-cell mediated anti-tumor immunity, hold immense promise for prevention and therapy of malignant diseases.